| Heading: |
Antimicrobials: Drug Resistance |
| Question ID: |
1785443 |
| UIN: |
38886 |
| House: |
Commons |
| Date tabled: |
2025-03-17 |
| Asking Member ID: |
5319 |
| Asking Member display name: |
Robin Swann
|
| Asking Member handle: |
RobinSwann_MP
|
| Asking Member Twitter reference: |
@RobinSwann_MP
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, whether he plans to make an assessment of the potential merits of including rapid diagnostics as part of the five-year action plan for antimicrobial resistance. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-03-25 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The United Kingdom’s 2024 to 2029 antimicrobial resistance (AMR) national action plan (NAP), published in May 2024, highlights the importance of accurate diagnostic testing to guide effective antibiotic use and tackle antimicrobial resistance. Supporting ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |